Transient lactose malabsorption in patients affected by symptomatic uncomplicated diverticular disease of the colon

Digestive Diseases and Sciences

Volumn 51, Issue 3, 2006, Pages 461-465

  Tursi, Antonio ^a,d   Brandimarte, Giovanni ^b   Giorgetti, Gian Marco ^c   Elisei, Walter ^b  

^a Lorenzo Bonomo Hospital   (Italy)

^b Cristo Re Hospital   (Italy)

^c S EUGENIO HOSPITAL   (Italy)

^d Galleria Pisani 4 ^*  (Italy)

Author keywords

Diverticular disease of the colon; Lactose malabsorption; Orocecal transit time; Small bowel bacterial overgrowth; Treatment

Indexed keywords

DEUTERIUM; LACTOSE; LACTULOSE; MESALAZINE; PENTACOL; RIFACOL; RIFAXIMIN;

ADULT; AGED; ARTICLE; BACTERIAL OVERGROWTH; CECUM; CLINICAL ASSESSMENT; CLINICAL TRIAL; COLON DIVERTICULOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HYDROGEN BREATH TEST; INTESTINE TRANSIT TIME; LACTOSE INTOLERANCE; MAJOR CLINICAL STUDY; MALE; MOUTH; PRIORITY JOURNAL; RECURRENT DISEASE; SMALL INTESTINE; STATISTICAL SIGNIFICANCE; SYMPTOM;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BREATH TESTS; CASE-CONTROL STUDIES; DIVERTICULUM, COLON; FEMALE; GASTROINTESTINAL TRANSIT; HUMANS; LACTOSE INTOLERANCE; LACTULOSE; MALE; MESALAMINE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; REFERENCE VALUES; RIFAMYCINS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 33645867665     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-3155-6     Document Type: Article

References (24)

1. Bayless TM, Rothfeld B, Massa C, Wise L, Paige D, Bedline MS: Lactose and milk intolerance: clinical implications. N Engl J Med 292:1156-1159, 1975
2. Flatz G: Genetics of lactose digestion in humans. Adv Human Genet 16:1-77, 1987
3. Bode S, Gudmand-Hoyer E: Incidence and clinical significance of lactose malabsorption in adult coeliac disease. Scand J Gastroenterol 32:484-488, 1988
4. Mishkin B, Yalovsky M, Mishkin S: Increased prevalence of lactose malabsorption in Crohn's disease patients at low risk for lactose malabsorption based on ethnic origin. Am J Gastroenterol 92:148-153, 1997
5. Tursi A: Clinical implications of delayed orocecal transit time and bacterial overgrowth in adult patients with Crohn's disease. J Clin Gastroenterol 32:274-275, 2001
6. Chiarioni G, Bassotti G, Germani U, et al.: Gluten-free diet normalizes mouth-to-cecum transit of a caloric meal in adult patients with celiac disease. Dig Dis Sci 42:2100-2105, 1997
7. Tursi A, Brandimarte G, Giorgetti GM, Nasi G: Assessment of orocecal transit time in different localisation of Crohn's disease and its possibile influence on clinical response to therapy. Eur J Gastroenterol Hepatol 15:69-74, 2003
8. Tursi A, Brandimarte G, Giorgetti GM: High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol 98:839-843, 2003
9. Tursi A: Acute diverticulitis of the colon - Current medical therapeutic management. Expert Opin Pharmacother 5:55-59, 2004
10. intestinal bacterial overgrowth: response to antibiotic treatment. Age Ageing 20:29-32, 1991
11. Colecchia A, Sandri L, Capodicasa S, Vestito A, Mazzella G, Staniscia T, Roda E, Festi D: Diverticular disease of the colon: new perspectives in symptom development and treatment. World J Gastroenterol 9:1385-1389, 2003
12. Tursi A, Brandimarte G, Giorgetti GM, Elisei W: Assessment of small intestinal bacterial overgowth in uncomplicated acute diverticulitis of the colon. World J Gastroenterol 11:2773-2776, 2004
13. Stollman NH, Raskin JB: Diagnosis and management of diverticular disease of the colon. Am J Gastroenterol 94:3110-3121, 1999
14. Kotler OP, Holt PR, Rosensweig NS: Modification of the breath test hydrogen test increased sensitivity fort he detection of carbohydrate malabsorption. J Lab Clin Med 100:798-805, 1982
15. Thompson DG, O'Brien JD, Hardie JM: Influence of the oropharyngeal microflora on the measurements of exhaled breath hydrogen. Gastroenterology 191:853-860, 1986
16. Rosenthal A, Solomons NW: Time-course of cigarette smoke contamination of clinical hydrogen breath-analysis tests. Clin Chem 29:1980-1981, 1983
17. Payne DL, Welsh JD, Claypool PL: Breath hydrogen (H2) response to carbohydrate malabsorption after exercise. J Lab Clin Med 102:147-150, 1983
18. Hirikawa M, Iida M, Korogi N, Fujishima M: Hydrogen breath test assessment of oro-cecal transit time: comparison with barium meal study. Am J Gastroenterol 83:1361-1363, 1988
19. Kerlin P, Wong L: Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 95:982-988, 1988
20. Sackett DL, Haynes RB, Tugwell B: Clinical Epidemiology. A Basic Science for Clinical Medicine. Boston, Little, Brown, 1985, pp 59-138
21. Tursi A: Factors influencing lactose intolerance. Eur J Clin Invest 34:314-315, 2004
22. Raguse T, Bubenzer J: Functional and morphological studies on diverticulosis of the large bowel. Chir Forum Exp Klin Forsch 138-143, 1979
23. Garcia-Olmo D, Sanchez PC: Patterns of colonic motility as recorded by a sham fecaloma reveal differences among patients with idiopathic chronic constipation. Dis Colon Rectum 4:480-489, 1998
24. Singh VV, Toskes PP: Small bowel bacterial overgrowth: presentation, diagnosis and treatment. Curr Treat Options Gastroenterol 7:19-28, 2004